Selective gene amplification to detect the T790M mutation in plasma from patients with advanced non-small cell lung cancer (NSCLC) who have developed epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) resistance-Reference-Cited by-同舟云学术

Selective gene amplification to detect the T790M mutation in plasma from patients with advanced non-small cell lung cancer (NSCLC) who have developed epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) resistance

Published:2018-03 Issue:3 Volume:10 Page:1431-1439
ISSN:2072-1439
Container-title:Journal of Thoracic Disease
language:
Short-container-title:J. Thorac. Dis.

Author:

Nishikawa Shingo,Kimura Hideharu,Koba Hayato,Yoneda Taro,Watanabe Satoshi,Sakai Tamami,Hara Johsuke,Sone Takashi,Kasahara Kazuo,Nakao Shinji

Publisher

AME Publishing Company

Subject

Pulmonary and Respiratory Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacophore-based virtual screening approaches to identify novel molecular candidates against EGFR through comprehensive computational approaches and in-vitro studies;Frontiers in Pharmacology;2022-11-15

2. Efficacy and Safety of First-Generation EGFR-TKIs Combined with Chemotherapy for Treatment-Naïve Advanced Non-Small-Cell Lung Cancer Patients Harboring Sensitive EGFR Mutations: A Single-Center, Open-Label, Single-Arm, Phase II Clinical Trial;Journal of Inflammation Research;2021-06

3. Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis;Scientific Reports;2021-04-16

4. All-in-one approaches for rapid and highly specific quantifcation of single nucleotide polymorphisms based on ligase detection reaction using molecular beacons as turn-on probes;Talanta;2021-03

5. Exploiting Kinase Inhibitors for Cancer Treatment: An Overview of Clinical Results and Outlook;Proteinkinase Inhibitors;2020